AI chest scans could help prevent early deaths by identifying patients who need intervention
The technology is aimed at helping those with sarcopenia, an age-related progressive loss of muscle mass and strength
Doctors could be assisted in pinpointing patients at risk of heart failure or death thanks to new AI scans measuring the size of a person’s chest muscles.
Listen to this article
Researchers used the technology to identify those with sarcopenia, an age-related progressive loss of muscle mass and strength.
The condition is common in older people with health problems but is rarely diagnosed as accurate measurements require specialised scans, leaving doctors to use simpler scores such as body mass index.
To overcome this, experts at Queen Mary, University of London developed a tool to give patients a sarcopenic obesity index, which is calculated using a person’s weight and size of the pectoral muscles in the chest.
Read more: Teenagers should be offered meningitis B jab on NHS, Government advisers say
Read more: New prime minister will not ‘change UK-Ukraine dynamic’, Keir Starmer vows
To get a score, a person’s weight in kilograms is divided by their pectoral muscle mass in grams.
For the study, published in the Journal of the American College of Cardiology, AI was used on the anonymised scans of more than 55,000 people.
After tracking patients’ health for an average of four years, the study found that among those with a sarcopenic obesity index score in the top 15%, more than half faced a higher risk of death from heart problems.
They also had a 37% risk of death from any cause, the study suggests, as well as a 31% higher chance of heart failure.
Lead author Dr Mihir Sanghvi, clinical lecturer in cardiology, said: "Aging and obesity are two of the most central health problems of our time, and both are key risk factors for heart disease.
"Sarcopenic obesity represents a meeting between the two – it is a crucial sign of health deterioration in obesity, especially for older people.
"We have developed a deep learning tool to measure this, in the hope that it will allow doctors and patients to take action to protect their health.
"This new tool can help identify people who most need interventions to prevent further muscle loss and a worsening of their condition."
Those with higher sarcopenic obesity index scores tended to be older, have higher blood pressure and blood sugar levels, were less likely to be active and more likely to come from a deprived area.
Researchers are hopeful the technology can be used to detect risks in people having a heart MRI scan, which was performed on around 125,000 NHS patients between 2023 and 2024.
The AI tool will be tested in clinical practice later this year.
Professor Bryan Williams, chief scientific medical officer at the British Heart Foundation, which funded the study, added: "This intriguing study demonstrates how the latest technologies could be used to expand our abilities to predict risk and save lives."